David J. Price

David J. Price

Auto-generated profile, based on publicly available information

David J. Price

Department of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 February 2020 in JAMA
Verified
Journal Article
Open access
PDF file
STSteven Y. C. Tong
Steven Y. C. Tong
DLDavid C. Lye
David C. Lye
DYDafna Yahav
Dafna Yahav
ASArchana Sud
Archana Sud
JRJ. Owen Robinson
J. Owen Robinson
FNfor the Australasian Society for Infectious Diseases Clinical Research Network
for the Australasian Society for Infectious Diseases Clinical Research Network
In 2017 in the United States, there were an estimated 120 000 cases of Staphylococcus aureus bacteremia resulting in 20 000 deaths.1 The mortality from S aureus bacteremia is higher for methicillin-resistant S aureus (MRSA) than for methicillin-susceptible S aureus (MSSA), typically at 20% to 25%.1,2 Despite the heavy burden of S aureus bacteremia, there is a paucity of evidence to guide treatment. Overall, there have been fewer than 2500 patients enrolled in published randomized clinical trials for S aureus bacteremia in the past 20 years, and fewer than 450 for MRSA bacteremia.3

27 May 2019 in Nature Genetics
Verified
Journal Article
Open access
PDF file
MDMark Davies
Mark Davies
LMLiam McIntyre
Liam McIntyre
AMAnkur Mutreja
Ankur Mutreja
JLJake Lacey
Jake Lacey
JLJohn A. Lees
John A. Lees
Mark Joseph WalkerMark Joseph Walker
Mark Joseph Walker
Group A Streptococcus (GAS; Streptococcus pyogenes) is a bacterial pathogen for which a commercial vaccine for humans is not available. Employing the advantages of high-throughput DNA sequencing technology to vaccine design, we have analyzed 2,083 globally sampled GAS genomes. The global GAS population structure reveals extensive genomic heterogeneity driven by homologous recombination and overlaid with high levels of accessory gene plasticity. We identified the existence of more than 290 clinically associated genomic phylogroups across 22 countries, highlighting challenges in designing vaccines of global utility. To determine vaccine candidate coverage, we investigated all of the previously described GAS candidate antigens for gene carriage and gene sequence heterogeneity. Only 15 of 28 vaccine antigen candidates were found to have both low naturally occurring sequence variation and high (>99%) coverage across this diverse GAS population. This technological platform for vaccine coverage determination is equally applicable to prospective GAS vaccine antigens identified in future studies.

1 August 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
NLNai-Chieh Liu
Nai-Chieh Liu
ETEileen L Troconis
Eileen L Troconis
LKLajos Kalmar
Lajos Kalmar
DPDavid J Price
David J Price
HWHattie E Wright
Hattie E Wright
JLJane Ladlow
Jane Ladlow
Extremely brachycephalic, or short-muzzled, dog breeds such as pugs, French bulldogs, and bulldogs are prone to the conformation-related respiratory disorder—brachycephalic obstructive airway syndrome (BOAS). Affected dogs present with a wide range of clinical signs from snoring and exercise intolerance, to life-threatening events such as syncope. In this study, conformational risk factors for BOAS that could potentially aid in breeding away from BOAS were sought. Six hundred and four pugs, French bulldogs, and bulldogs were included in the study. Soft tape measurements of the head and body were used and the inter-observer reproducibility was evaluated. Breed-specific models were developed to assess the associations between the conformational factors and BOAS status based on functional grading. The models were further validated by means of a BOAS index, which is an objective measurement of respiratory function using whole-body barometric plethysmography. The final models have good predictive power for discriminating BOAS (-) and BOAS (+) phenotypes indicated by the area under the curve values of >80% on the receiver operating curves. When other factors were controlled, stenotic nostrils were associated with BOAS in all three breeds; pugs and bulldogs with higher body condition scores (BCS) had a higher risk of developing BOAS. Among the standardized conformational measurements (i.e. craniofacial ratio (CFR), eye width ratio (EWR), skull index (SI), neck girth ratio (NGR), and neck length ratio (NLR)), for pugs EWR and SI, for French bulldogs NGR and NLR, and for bulldogs SI and NGR showed significant associations with BOAS status. However, the NGR in bulldogs was the only significant predictor that also had satisfactory inter-observer reproducibility. A NGR higher than 0.71 in male bulldogs was predictive of BOAS with approximately 70% sensitivity and specificity. In conclusion, stenotic nostrils, BCS, and NGR were found to be valid, easily applicable predictors for BOAS (+).

17 February 2022 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
MAMaria Auladell
Maria Auladell
HPHoang Vu Mai Phuong
Hoang Vu Mai Phuong
LMLe Thi Quynh Mai
Le Thi Quynh Mai
YTYeu-Yang Tseng
Yeu-Yang Tseng
LCLouise Carolan
Louise Carolan
AFAnnette Fox
Annette Fox

13 August 2020 in eLife
Verified
Journal Article
Open access
DPDavid J Price
David J Price
FSFreya M Shearer
Freya M Shearer
MMMichael T Meehan
Michael T Meehan
EMEmma McBryde
Emma McBryde
RMRobert Moss
Robert Moss
JMJames McCaw
James McCaw
As of 1 May 2020, there had been 6808 confirmed cases of COVID-19 in Australia. Of these, 98 had died from the disease. The epidemic had been in decline since mid-March, with 308 cases confirmed nationally since 14 April. This suggests that the collective actions of the Australian public and government authorities in response to COVID-19 were sufficiently early and assiduous to avert a public health crisis – for now. Analysing factors that contribute to individual country experiences of COVID-19, such as the intensity and timing of public health interventions, will assist in the next stage of response planning globally. We describe how the epidemic and public health response unfolded in Australia up to 13 April. We estimate that the effective reproduction number was likely below one in each Australian state since mid-March and forecast that clinical demand would remain below capacity thresholds over the forecast period (from mid-to-late April).

23 January 2024 in Nature Microbiology
Verified
Journal Article
Open access
PDF file
PMPeter Mee
Peter Mee
ABAndrew H. Buultjens
Andrew H. Buultjens
JOJane Oliver
Jane Oliver
KBKaren Brown
Karen Brown
JCJodie C. Crowder
Jodie C. Crowder
SLStacey E. Lynch
Stacey E. Lynch
Buruli ulcer, a chronic subcutaneous infection caused by Mycobacterium ulcerans, is increasing in prevalence in southeastern Australia. Possums are a local wildlife reservoir for M. ulcerans and, although mosquitoes have been implicated in transmission, it remains unclear how humans acquire infection. We conducted extensive field survey analyses of M. ulcerans prevalence among mosquitoes in the Mornington Peninsula region of southeastern Australia. PCR screening of trapped mosquitoes revealed a significant association between M. ulcerans and Aedes notoscriptus. Spatial scanning statistics revealed overlap between clusters of M. ulcerans-positive Ae. notoscriptus, M. ulcerans-positive possum excreta and Buruli ulcer cases, and metabarcoding analyses showed individual mosquitoes had fed on humans and possums. Bacterial genomic analysis confirmed shared single-nucleotide-polymorphism profiles for M. ulcerans detected in mosquitoes, possum excreta and humans. These findings indicate Ae. notoscriptus probably transmit M. ulcerans in southeastern Australia and highlight mosquito control as a Buruli ulcer prevention measure.